- Home
- DOYU vs RNAC Comparison
DOYU vs RNAC Comparison
Compare DOYU & RNAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DOYU | RNAC |
|---|---|---|
| Founded | 2014 | 2007 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Programming Data Processing | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 153.0M | 168.3M |
| IPO Year | 2019 | 2016 |
Fundamental Metrics
Financial Performance| Metric | DOYU | RNAC |
|---|---|---|
| Price | $4.98 | $6.75 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 5 |
| Target Price | $7.00 | ★ $34.00 |
| AVG Volume (30 Days) | 15.7K | ★ 163.7K |
| Earning Date | 05-19-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $2,797,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $4.28 | $5.60 |
| 52 Week High | $9.34 | $14.56 |
Technical Indicators
Market Signals| Indicator | DOYU | RNAC |
|---|---|---|
| Relative Strength Index (RSI) | 50.55 | 52.71 |
| Support Level | $4.71 | $6.54 |
| Resistance Level | $5.07 | $7.81 |
| Average True Range (ATR) | 0.16 | 0.47 |
| MACD | 0.04 | 0.12 |
| Stochastic Oscillator | 56.25 | 61.50 |
Price Performance
Historical ComparisonAbout DOYU DouYu International Holdings Limited ADS
DouYu International Holdings Ltd is a game-centric live streaming platform in China and a pioneer in the eSports value chain. The company operates its platform on both PC and mobile apps, through which users can enjoy immersive and interactive games and entertainment live streaming. It generates revenues through live streaming and advertisement.
About RNAC Cartesian Therapeutics Inc.
Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering cell therapy for the treatment of autoimmune diseases. The company uses technology and a manufacturing platform to introduce mRNA into cells to provide a therapeutic effect to patients suffering from a variety of autoimmune conditions. Unlike DNA, mRNA degrades naturally over time without integrating into the cell's genetic material.